Antiviral Activity of Ingavirin® in Experimental Lethal Influenza Due to Influenza Virus B in Albino Mice

Antibiotiki i Khimioterapiya

Volumn 55, Issue 3-4, 2010, Pages 8-11

  Zarubaev, V V ^a   Garshinina, A V ^a   Kalinina, N A ^a   Shtro, A A ^a   Nebolsin, V E ^b   Kiselev, O I ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b JSC Valenta Pharm   (Russian Federation)

Author keywords

Antiviral chemotherapy; Influenza; Ingavirin ; Virus B

Indexed keywords

AMIDE; ANTIVIRUS AGENT; DICARBOXYLIC ACID; IMIDAZOLE DERIVATIVE; PENTANEDIOIC ACID IMIDAZOLYL ETHANAMIDE;

ANIMAL; ARTICLE; FEMALE; INFLUENZA VIRUS B; MORTALITY; MOUSE; ORTHOMYXOVIRUS INFECTION; VIROLOGY;

AMIDES; ANIMALS; ANTIVIRAL AGENTS; DICARBOXYLIC ACIDS; FEMALE; IMIDAZOLES; INFLUENZA B VIRUS; MICE; ORTHOMYXOVIRIDAE INFECTIONS;

ANIMALIA; INFLUENZA B VIRUS; INFLUENZAVIRUS B; MUS;

EID: 77954695209     PISSN: 02352990     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. http://www.who.int/csr/don/2009-ll-13/en/index.html
2. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65:55-63.
3. Scholtissek C, Quack G, Klenk H. D., Webster R. G. How to overcome resistance of influenza A viruses against adamantane derivatives. Antiviral Res 1998; 37:83-95.
4. Woodhead M., Lavanchy D., Johnston S. et al. Neuraminidase inhibitors: progress in the management of influenza. Int J Clin Pract 2000; 54:9:604-610.
5. Reed L. J., Muench H. A simple method of estimating fifty percent end-points. Am J Hyg 1938; 27:493-497.